Arnatar Therapeutics

Last updated: August 28, 2025
CEO - Xuehai Liang
CEO - Xuehai Liang
Country: USA | Funding: $64.3M (+)

Website: https://www.arnatar.com/

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Competitors